Several studies suggested a causal link between AML1 gene rearrangements and both radiation-induced acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS). Fifty-three AML samples were analyzed for the presence of AML1 abnormalities using fluorescent in-situ hybridization (FISH) and reverse transcription polymerase chain reaction (RT-PCR). Of these patients, 24 had experienced radiation exposure due to the Chernobyl accident, and 29 were non-irradiated spontaneous AML cases and served as controls. AML1/ETO translocations were found in 9 of 29 spontaneous AML but only in 1 of 24 radiation-associated AML cases. This difference between translocation frequencies is statistically significant in the age-unstratified cohorts (p=0.015). Following age stratification, the difference becomes less pronounced but remains on borderline significance (p=0.053). AML1 mutation status was assessed in 5 clean-up workers at Chernobyl NPP with MDS, or AML following MDS, by direct sequencing of genomic DNA from the coding region (exon 3 through 8). In one patient who developed MDS following an acute radiation syndrome, a hexanucleotide duplication of CGGCAT in exon 8 was found, inserted after base position 1502. Our results suggest that AML1 gene translocations are infrequent in radiation-induced leukemogenesis but are consistent with the idea that radiation may contribute to the development of MDS through AML1 gene mutation.

Download full-text PDF

Source
http://dx.doi.org/10.1269/jrr.46.249DOI Listing

Publication Analysis

Top Keywords

aml1 gene
16
gene rearrangements
8
acute myeloid
8
myelodysplastic syndromes
8
spontaneous aml
8
aml cases
8
aml1
6
aml
6
mds
5
rearrangements mutations
4

Similar Publications

Article Synopsis
  • The study aimed to investigate the immune landscape and immune cell roles in the progression of acute lymphoblastic leukemia (ALL), focusing particularly on the ETV6-RUNX1 genetic alteration common in childhood cases.
  • Using advanced techniques like single-cell RNA sequencing, researchers analyzed B progenitor cells from bone marrow samples, identifying specific gene expressions and pathways that may drive rapid cell cycle progression in ALL.
  • Results highlighted distinct clusters of B progenitor cells, particularly one with amplified genes on chromosome 6p that were linked to increased cell cycle activity, underscoring the complexity of immune interactions in the disease's progression.
View Article and Find Full Text PDF

Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells.

Cancer Res

December 2024

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Metabolism plays a key role in the maintenance of normal hematopoietic stem cells (HSC) and in the development of leukemia. A better understanding of the metabolic characteristics and dependencies of preleukemic cells could help identify potential therapeutic targets to prevent leukemic transformation. As AML1-ETO, one of the most frequent fusion proteins in acute myeloid leukemia that is encoded by a RUNX1::RUNX1T1 fusion gene, is capable of generating preleukemic clones, in this study, we used a conditional Runx1::Runx1t1 knockin mouse model to evaluate preleukemic cell metabolism.

View Article and Find Full Text PDF

Shikonin, a natural naphthoquinone phytochemical, exerts anti-leukemia effects in human CBF-AML cell lines and zebrafish xenograft models.

Biomed Pharmacother

October 2024

Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 970374, Taiwan; Laboratory of Medical Genetics, Genetic Counseling Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970374, Taiwan. Electronic address:

Article Synopsis
  • * Shikonin (SHK), a compound found in traditional Chinese medicine, shows promise in reducing CBF-AML cell viability by inducing cell cycle arrest, promoting apoptosis, and altering gene expression related to leukemia progression.
  • * Animal studies demonstrated that SHK is safe in zebrafish and effectively inhibits leukemia cell growth, especially when combined with cytarabine, highlighting its potential as a new chemotherapy option for CBF-AML.
View Article and Find Full Text PDF
Article Synopsis
  • Aberrant gene expression in acute myeloid leukemia (AML) with translocations is linked to the dysregulation of epigenetic modifiers, specifically involving the AML1/ETO fusion protein.
  • The study aimed to pinpoint critical epigenetic modifiers essential for the survival and growth of AML1/ETO-positive AML cells through shRNA library screens and transcriptomics.
  • Researchers identified and validated 41 essential genes, including DNMT1 and ATR, which can be inhibited by specific drugs, showing potential for effective treatment strategies in AML1/ETO-positive patients.
View Article and Find Full Text PDF

Systemic mastocytosis (SM) with RUNX1-RUNX1T1 positive acute myeloid leukemia (AML) is a rare myeloid tumor with no standard treatment. Two cases of SM patients with RUNX1-RUNX1T1 positive AML treated with sequential avapritinib after allogeneic hematopoietic stem cell transplantation (allo-HSCT) were reported in Henan Cancer Hospital. Mast cell in bone marrow disappeared, C-KIT mutation and RUNX1-RUNX1T1 fusion gene remained negative.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!